Related Experiment Video
Updated: Feb 26, 2026

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
Published on: February 6, 2020
Technical Note: Empirical altitude correction factors for well chamber measurements of permanent prostate and breast
Elizabeth Watt1,2, David P Spencer1,2,3, Tyler Meyer1,2,3
1Department of Physics & Astronomy, University of Calgary, Calgary, AB, T2N 1N4, Canada.
Purpose:
Previous studies in the literature have measured an altitude effect for low-energy brachytherapy seeds; a correction factor applied in addition to PTP to account for the breakdown of Bragg-Gray cavity theory at low energies in well-type ionization chambers. In clinical practice, many centers use altitude correction factors that are not seed-model-specific. The purpose of this work is to present altitude correction factors for several seed models without documented factors in the literature.
Methods:
An in-house constructed pressure vessel was used with a well-type ionization chamber to measure the air-kerma strength of the IsoAid Advantage (Pd-103), Theragenics AgX100 (I-125), and Nucletron selectSeed (I-125) at a pressure range representative of those encountered worldwide. The TheraSeed 200 (Pd-103) was also measured for comparison to the originally published correction factor for validation of the experimental process. When correction factors derived in this work were within experimental uncertainties of those published, no new correction factors were proposed.
Results:
The three seed models measured herein all demonstrated a similar response to change in pressure as previously documented in the literature with the HDR 1000 Plus well-type ionization chamber. Correction factors of the functional form PA=k1(P[torr])k2, consistent with those previously published, were found to be appropriate for these seed models. A new correction factor is proposed for the Theragenics AgX100 and Nucletron selectSeed (k1 = 0.0417, k2 = 0.479). The IsoAid Advantage, however, agreed to within uncertainty with the published altitude correction factor for the TheraSeed 200; thus the application of the same correction factor is appropriate (k1 = 0.0241, k2 = 0.562).
Conclusions:
This work presents altitude correction factors for three permanent implant brachytherapy seed models in clinical use. This will allow clinics to utilize model-specific factors, reducing systematic errors in their air-kerma strength verifications.
More Related Videos
06:20Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
07:31Characterization of Recombination Effects in a Liquid Ionization Chamber Used for the Dosimetry of a Radiosurgical Accelerator
Published on: May 9, 2014
Related Concept Videos
Distance Corrections
Influence of Earth's Curvature and Atmospheric Refraction on Leveling
Application of Linearization and Approximation